Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04401995
Title Study of TLR9 Agonist CMP-001 in Combination With Nivolumab vs. Nivolumab
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Diwakar Davar
Indications

skin melanoma

Therapies

Nivolumab

Nivolumab + QbG10

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.